Amylyx Pharmaceuticals Inc (AMLX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 43,779 | 36,604 | 36,027 | 42,857 | 37,803 |
| Operating Income | -43,779 | -36,604 | -36,027 | -42,857 | -37,803 |
| Other Income | 2,495 | 3,651 | 1,641 | 1,414 | 1,896 |
| Pre-tax Income | -41,284 | -32,953 | -34,386 | -41,443 | -35,907 |
| Net Income Continuous | -41,284 | -32,999 | -34,386 | -41,443 | -35,907 |
| Net Income | $-41,284 | $-32,999 | $-34,386 | $-41,443 | $-35,907 |
| EPS Basic Total Ops | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 |
| EPS Basic Continuous Ops | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 |
| EPS Diluted Total Ops | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 |
| EPS Diluted Continuous Ops | -0.37 | -0.28 | -0.37 | -0.46 | -0.42 |
| EPS Diluted Before Non-Recurring Items | -0.37 | -0.30 | -0.37 | -0.46 | -0.42 |
| EBITDA(a) | $-44,290 | $-37,553 | $-37,150 | $-44,239 | $-39,350 |